中国性科学
中國性科學
중국성과학
THE CHINESE JOURNAL OF HUMAN SEXUALITY
2015年
5期
32-34
,共3页
去氧孕烯炔雌醇%宫颈子宫内膜异位症%宫颈糜烂
去氧孕烯炔雌醇%宮頸子宮內膜異位癥%宮頸糜爛
거양잉희결자순%궁경자궁내막이위증%궁경미란
Desogestrel and ethinylestradiol%Cervical endometriosis%Cervical erosion
目的：探讨去氧孕烯炔雌醇预防宫颈子宫内膜异位症的效果，总结临床经验，为今后该类患者的防治工作提供理论依据。方法：选取2011年6月至2013年6月间医院收治的68例行物理手段治疗宫颈糜烂的患者作为样本。将其随机分为两组，对照组34例患者，术后行抗生素治疗；治疗组34例患者在此基础上加以口服去氧孕烯炔雌醇2个月进行治疗。比较两组患者术中出血量、术后宫颈愈合时间、宫颈子宫内膜异位症发生情况。结果：治疗组的患者平均术中出血量为（4.64±1.72）mL，低于对照组的（6.98±3.02）mL，差异有统计学意义；治疗组的患者宫颈平均愈合时间为（1.12±0.34）个月，低于对照组的（1.24±0.41）个月，但差异无统计学意义；治疗组的患者无一例发生宫颈子宫内膜异位症，对照组共4例患者发生子宫内膜异位症；治疗组宫颈子宫内膜异位症的发生率低于对照组，差异有统计学意义；观察组患者服药期间均无阴道出血，分泌物正常，对照组患者3例发生阴道点滴出血，1例患者阴道出现脓性分泌。结论：去氧孕烯炔雌醇可以减少术中出血量，缩短物理治疗后宫颈愈合时间，减少宫颈子宫内膜异位症的发生率，起到预防子宫内膜异位症的作用。且去氧孕烯炔雌醇的不良反应轻微，值得在临床工作中推广、应用。
目的：探討去氧孕烯炔雌醇預防宮頸子宮內膜異位癥的效果，總結臨床經驗，為今後該類患者的防治工作提供理論依據。方法：選取2011年6月至2013年6月間醫院收治的68例行物理手段治療宮頸糜爛的患者作為樣本。將其隨機分為兩組，對照組34例患者，術後行抗生素治療；治療組34例患者在此基礎上加以口服去氧孕烯炔雌醇2箇月進行治療。比較兩組患者術中齣血量、術後宮頸愈閤時間、宮頸子宮內膜異位癥髮生情況。結果：治療組的患者平均術中齣血量為（4.64±1.72）mL，低于對照組的（6.98±3.02）mL，差異有統計學意義；治療組的患者宮頸平均愈閤時間為（1.12±0.34）箇月，低于對照組的（1.24±0.41）箇月，但差異無統計學意義；治療組的患者無一例髮生宮頸子宮內膜異位癥，對照組共4例患者髮生子宮內膜異位癥；治療組宮頸子宮內膜異位癥的髮生率低于對照組，差異有統計學意義；觀察組患者服藥期間均無陰道齣血，分泌物正常，對照組患者3例髮生陰道點滴齣血，1例患者陰道齣現膿性分泌。結論：去氧孕烯炔雌醇可以減少術中齣血量，縮短物理治療後宮頸愈閤時間，減少宮頸子宮內膜異位癥的髮生率，起到預防子宮內膜異位癥的作用。且去氧孕烯炔雌醇的不良反應輕微，值得在臨床工作中推廣、應用。
목적：탐토거양잉희결자순예방궁경자궁내막이위증적효과，총결림상경험，위금후해류환자적방치공작제공이론의거。방법：선취2011년6월지2013년6월간의원수치적68례행물리수단치료궁경미란적환자작위양본。장기수궤분위량조，대조조34례환자，술후행항생소치료；치료조34례환자재차기출상가이구복거양잉희결자순2개월진행치료。비교량조환자술중출혈량、술후궁경유합시간、궁경자궁내막이위증발생정황。결과：치료조적환자평균술중출혈량위（4.64±1.72）mL，저우대조조적（6.98±3.02）mL，차이유통계학의의；치료조적환자궁경평균유합시간위（1.12±0.34）개월，저우대조조적（1.24±0.41）개월，단차이무통계학의의；치료조적환자무일례발생궁경자궁내막이위증，대조조공4례환자발생자궁내막이위증；치료조궁경자궁내막이위증적발생솔저우대조조，차이유통계학의의；관찰조환자복약기간균무음도출혈，분비물정상，대조조환자3례발생음도점적출혈，1례환자음도출현농성분비。결론：거양잉희결자순가이감소술중출혈량，축단물리치료후궁경유합시간，감소궁경자궁내막이위증적발생솔，기도예방자궁내막이위증적작용。차거양잉희결자순적불량반응경미，치득재림상공작중추엄、응용。
Objectives:To investigate the effect of desogestrel and ethinylestradiol in preventing cervical endometriosis;to summarize the clinical experience to provide a theoretical basis for future prevention and treatment of these patients.Methods:68 cervical erosion patients receiving routine physical treatment from June 2011 to June 2013 were selected and randomly divided into two groups:control group of 34 patients to receive postoperative anti-biotic therapy;treatment group of 34 patients to receive additional desogestrel and ethinylestradiol for two months o-rally.The blood loss,postoperative healing time of the cervix,cervical endometriosis occurrence of the two groups was compared.Results:The mean blood loss for patients in the treatment group (4.64 ±1.72)mL was lower than the control group (6.98 ±3.02)mL,with statistically significant difference;the average healing time of cervix in the treatment group (1.12 ±0.34 months)was lower than the control group (1.24 ±0.41)months,without sta-tistically significant difference;there was no case of cervical endometriosis in the treatment group,but a total of four cases in the control group,with statistically significant difference in the incidence of cervical endometriosis;no vagi-nal bleeding during medication in the observation group with normal secretions,but there were three cases of vaginal spotting and one case of purulent vaginal secretion in the control group.Conclusion:Desogestrel and ethinylestradi-ol can reduce blood loss,shorter healing time after cervical physical therapy and reduce the incidence of cervical en-dometriosis,thusly preventing endometriosis.Meanwhile,desogestrel and ethinylestradiol is of slight adverse reac-tion,worthy promotion and application in clinic.
